IMBdx

02/09/2022

We are excited to attend the upcoming congress in Paris next week👍!
Visit us at IMBdx Booth #434 to learn more about our advancements in precision oncology research using liquid biopsy.

07/04/2022

IMBdx is excited to present our THREE latest studies on at , New Orleans, on April 8-13.



#2800 https://lnkd.in/ghTHBGET
#5157 https://lnkd.in/gwyFVszZ
#5164 https://lnkd.in/gXJASB9B

24/01/2022

“During long treatments for cancer, we can detect resistance and immediately apply the right treatment for that resistance.”
Read this featured article on Nature magazine's Focal Point to learn more about IMBdx and our AlphaLiquid test:

Easy-to-perform liquid biopsies promise to detect cancer earlier and enable doctors to more easily monitor response to treatment.

09/08/2021

Revolutionizing the way cancer is diagnosed, monitored, and treated. With just a single collection of blood, AlphaLiquid helps establish a personalized treatment strategy for each individual patient.

Learn more about AlphaLiquid test: www.imbdx.com/eng
Contact our representative: [email protected]